ANTIVIRAL AND ANTIRETROVIRAL DRUGS 1 University Of Nairobi Department Of Public Health, Pharmacology & Toxicology JPT 341 Pharmacology &Toxicology BVM.

Slides:



Advertisements
Similar presentations
Pathogenesis and Control of Viral Infections Chapter 30.
Advertisements

D7 - Antivirals. D.7.1 State how viruses differ from bacteria.
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Twelfth Edition© 2015 Pearson Education, Inc Viruses HIV causes AIDS, which.
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Lecture 29: Viruses 0.5 m.
Lecture 27 Pharmacology Flint et al., Chapter 19, pp. 725 – 757.
Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies.
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Eleventh Edition Copyright © 2012 by Pearson Education, Inc. Chapter 17 Nucleic.
D7 - Antivirals Differences between bacteria and viruses How does antiviral drugs work? The AIDS problem.
Antiviral Agents.
Genetic Mutations A mutation alters the nucleotide sequence in DNA, which can cause a change in the amino acid structure of the corresponding protein,
Anti-viral drugs Viruses have no cell wall and made up of nucleic acid components Viruses containing envelope – antigenic in nature Viruses are obligate.
September 15, 1997Copyright Robert Rapp, University of Kentucky College of Pharmacy Viral Infections Part 1 and 2 Robert P. Rapp, Pharm. D. Professor College.
Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.
Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.
Antiviral Agents Restricted spectrum
By: Lana & Layal Abuhamdeh. VIRUSES  Viruses are much smaller than bacteria  Many different types of virus, vary in shape and structure  All viruses.
Virology – Antivirals 1 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Antiviral Drugs Prof. Alhaider, 1431 H Definition: Viral infections depend on the host cells. Therefore, antiviral drugs must block viral entry or exit.
VIRUSES NONLIVING PARTICLES. Viruses  Smaller than bacteria  Known since late 1800’s but no way to study them  1935 Tobacco mosaic virus was crystallized.
Antivirals. Structure of a Virus all viruses- o have a central core of DNA or RNA o surrounded by a coat(capsid) of packed protein units(capsomers) UNLIKE.
Medicines and Drugs Anti-virals Julia Barnes Anna Cruickshank.
Learning Objectives: Nucleic Acid therapeutics ReadingChapter 4, p from Blackburn & Gait Know the general mechanisms of the anti-cancer drugs.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Antiviral Drugs. Mechanism of Action Picornaviruses eg, polioviruses, cold viruses Block attachment molecule on host cell or pathogen Attachment antagonists.
Antiviral Agents.
Treatment The complicated Hepatitis – Chronic hepatitis requires expensive treatment – antiviral drugs – Lamivudine and immune modulators – Interferons.
The Practical Side of Nucleotide Metabolism November 29, 2001.
Antiviral Agents, chapter 39 Different living organisms.
Anti-viral drugs By Dr.Mohamed Abd ALMoneim Attia.
Acquired Immunodeficiency Syndrome AIDS
Antiviral therapy E.McNamara. Challenges Virus parasitize host cells Target the virus specifically Latency, quiescent phase Is treatment necessary? Efficacy.
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.
Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)
Antivirals Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy 1. viral attachment to cell and fusion (fusion inhibitors) 2. protein translation in infected.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Antiviral drugs.
Although bacitracin has found its widest use in topical preparations for local infections, it is quite effective in several systemic and local infections.
Antiviral Therapy. Table for antiviral Drug:Viruses: Chemical Type: Target: Acyclovir, VidarabineHerpesviruses (HSV) Nucleoside analogues Virus polymerase.
Antiviral Agents Dr. Yunita Sari Pane, MS 06 August DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
University of Karbala College of veterinary medicine Second semester Pharmacology Lect. # 3 Antiviral Drugs Dr. Sattar K. Abdul-Hussain, Ph.D, DVM, DABT.
Antiviral agents Hamzeh Elayan
Pharmacology of Antiviral Agents
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral Drugs.
Antivirals Essential idea
Antiviral Medications
By Dr.Mohamed Abd ALMoneim Attia
Antivirals Essential idea
ANTIFUNGALS Fungus single cell organism with cell wall has chitin, no chlorophyhll. reproduction by spores. study is mycology most are resistant.
Antiviral chemotherapy
Antiviral Drugs.
Antiviral drugs Mr. OLORO JOSEPH..
School of Pharmacy, University of Nizwa
Antivirals Essential idea
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral Agents.
Review on Infectious Diseases and Management
Antiviral agents.
Antiviral chemotherapy
Presentation transcript:

ANTIVIRAL AND ANTIRETROVIRAL DRUGS 1 University Of Nairobi Department Of Public Health, Pharmacology & Toxicology JPT 341 Pharmacology &Toxicology BVM 3 RD Year Lecture Notes Dr Aboge, G.O. BVM, Msc, PhD 2014

Lecture objectives 1.By the end of this lecture the students should be able;  To give major groups and specific examples of the antiviral and antiretroviral drugs.  To describe the mechanisms of action of antiviral and antiretroviral drugs including their pharmacological effects.  To outline clinical applications the drugs in vet medicine. 2

Lecture outline Introduction Classification of antiviral and antiretroviral drugs Pyrimidine nucleosides analogues: Idoxuridine Purine nucleosides analogues: Acyclovir, Ganciclovir Antiviral prodrugs: Ribavirin and Oseltamivir) Cyclic amine antiviral drugs: Amantadine Antiretrovirals: azidothymidine, Biologic Response Modifiers: Interferon, cytockines. 3

Introduction Antiviral and antiretroviral agents are compounds active against viruses including retroviruses. Since viruses are obligate intracellular microorganisms, drugs that target viral processes must penetrate host cells. Therefore, drugs that negatively impact on a virus are also likely to negatively impact normal pathways of the host. Consequently, antiviral drugs have a narrow therapeutic margin as compared to antibacterial drugs. 4

Classification of antifungal drugs Based on chemical structures: The classes include pyrimidine nucleosides, purine nucleosides analogues and antimetabolites prodrugs. Based on their modification of host biological functions: Biologic Response Modifiers like cytokines Based on the type of viruses they act on: DNA based viruses or RNA based retroviruses Miscellaneous antiviral drugs 5

Pyrimidine nucleosides analogues Pyrimidine nucleoside analogues mimics pyrimidine nucleosides in their chemical structures and includes Idoxuridine and Trifluridine. 6 IdoxuridineTrifluridine Pyrimidine nucleosides Deoxythymidine Deoxythymidine analogues

Mechanisms of actions of idoxuridine and trifluridine The pyrimidine nucleosides analogues substitute pyrimidine for thymidine, causing defective DNA molecules. In particular, idoxuridine inhibits viral replication by substituting itself for thymidine in viral DNA. This in turn inhibits the functions of thymidylate phosphorylase and viral DNA polymerases resulting in inability of the virus to reproduce and infect tissue. 7

Mechanisms of action of idoxuridine and trifluridine The mechanism of action of trifluridine has not been fully determined, but is thought to inhibit viral replication. It does this by incorporating into viral DNA during replication and forms defective proteins and cause an increased mutation rate. This drug also reversibly inhibits thymidylate synthetase, an enzyme that is necessary for DNA synthesis. 8

Clinical applications of idoxuridine and trifluridine Idoxuridine is effective against herpesvirus infection of the superficial layers of the cornea (herpesvirus keratitis) and of the skin, but is toxic when administered systemically. Trifluridine is the agent of choice for the treatment of herpesvirus keratitis in humans. 9

Purine nucleosides analogues These purine nucleoside analogues mimics guanosine nucleosides in their chemical structures and includes vidarabine acyclovir, and ganciclovir. 10 Acyclovir, vidarabine Ganciclovir Guanosine

Mechanisms of actions Vidarabine is phosphorylated by cellular kinases to a triphosphate compound, which is an inhibitor and a substrate of viral DNA polymerase. When used as a substrate for viral DNA polymerase, the phosphrylated compound competitively inhibits dATP leading to the formation of ‘faulty’ DNA. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand Herpesviral enzymes are ~20-fold more susceptible to the drug compared with host DNA. (plasma half life= 4hr). 11

Mechanisms of actions Acyclovir is phosphorylated by virus-induced thymidine kinase to the triphosphate form, which is a better substrate and inhibitor of viral DNA polymerase, compared with host. Binding to DNA polymerase is irreversible and once incorporated into viral DNA, the DNA chain is terminated. The mechanism of action of ganciclovir is similar to that of acyclovir. 12

Clinical applications Herpesviral enzymes are ~20-fold more susceptible vidarabine compared with host DNA. Vidarabine is effective against chickenpox - varicella, herpes zoster and herpes simplex. Acyclovir is useful against the herpesvirus family and is available as an ophthalmic ointment, a topical ointment and cream, an IV preparation, and oral formulations. Ganciclovir is effective against human cytomegalovirus. 13

Side effects Ganciclovir use may cuase neutropenia and thrombocytopenia, fever, rash, GIT symptoms, confusion and seizure. Vidarabine may cause bone marrow suppression and CNS problems when high blood levels are reached. 14

Antiviral prodrugs 15 Ribavirin is a synthetic triazole nucleoside while is Oseltamivir an acetamido cyclohexene that is analogue of sialic acid Ribavirin Oseltamivir

Mechanism of action of ribavirin Ribavirin is readily phosphorylated intracellularly by adenosine kinase to ribavirin triphosphate. Ribavirin triphosphate is a potent competitive inhibitor of inosine monophosphate (IMP) dehydrogenase, viral RNA polymerase and viral mRNA guanylyltransferase. Guanylyltranserase inhibition stops the capping of mRNA 16

Mechanism of action of ribavirin This causes a marked reduction of intracellular guanosine triphosphate pools and inhibition of viral RNA and protein synthesis. Ribavirin is also incorporated into the viral genome causing lethal mutagenesis and a subsequent decrease in specific viral infectivity. 17

Clinical uses of ribarivin Ribavirin has a broad spectrum of activity against many RNA and DNA viruses. It is active against adenoviruses, herpesviruses, orthomyxoviruses, paramyxoviruses, poxviruses, picornaviruses, rhabdoviruses, rotaviruses, and retroviruses. Ribavirin does not have a wide margin of safety in domestic animals 18

Mechanism of action of oseltamivir Oseltamivir is hydrolysed to oseltamivir carboxylate, the active form, which inhibits influenza virus neuraminidase and thus may alter virus particle aggregation and release. Oseltamivir (Tamiflu) is effective against influenza infection in and has been used for the prophylaxis of influenza in humansr 19

Cyclic amine antiviral drugs Amantadine and rimantadine, are cyclic amine antiviral drugs. 20 Amantadine Rimantadine

Mechanisms of actions of cyclic amine antiviral drugs Amantadine drug interferes with a viral protein, M2 (an ion channel needed for the viral particle to become "uncoated" once it infects the cell. This leads to inhibition or delay of the uncoating process that precedes primary transcription. Amantadine may also interfere with the early stages of viral mRNA transcription. It is absorbed from the GI tract, and ~90% of a dose administered PO is excreted unchanged in the urine over several days (human data). 21

Mechanisms of actions of cyclic amine antiviral drugs The mechanism of action of rimantadine is not fully understood. It appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. 22

Indications and side effects of amantadine Amantadine at usual concentrations inhibits replication of influenza A and C viruses, Sendai virus, and pseudorabies virus. It is used clinically to prevent infection with various strains of influenza A viruses. It produces few adverse effects, related to the CNS including stimulation of the CNS at very high doses. 23

Antiretroviral drugs Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV. 24 Lamivudine Synthetic nucleoside analogue Thymidine analogue Azidothymidine, AZT Synthetic purine derivative Efavirenz

Mechanisms of actions of antiretroviral drugs Generally, antiretroviral drugs inhibits retroviral reverse transcriptase and subsequent DNA transcription in host cells preventing viral replication. In particular, AZT inhibits viral reverse transcriptase, which converted the viral RNA into double-stranded DNA before it is integrated into the host cell genome and prevents viral replication. Efavirenz also inhibits the activity of viral reverse transcriptase but the drug must be converted intracellularly to the active triphosphorylated form. 25

Clinical use of antiretroviral drugs These drugs are mainly used in management of HIV and are of limited use in veterinary medicine The drugs are effective for acute infections but are relatively ineffective for chronically infected cells because they inhibit early viral replication. Granulocytopenia and anemia are the major adverse effects of AZT in human patients 26

Biologic response modifiers Biologic response modifiers include cytokines such as;  Interferons (IFN),  Interleukins (IL),  Hematopoietic growth factors Recombinant Interferon Alfa-2a has been produced 27

Mechanisms of actions of interferon 2α Interferons modulate the host immune response and thus may help in fighting viral infections. They bind to receptors on other cells and induce antiviral proteins that protect the cell from infection. IFNs also have antitumor, antiparasitic, and immuno- modulatory effects. 28

Clinical application of BRM Recombinant Interferon Alfa-2a may be used for treatment of chronic hepatitis C, and oral warts arising from HIV infection. In veterinary medicine, Interferon α-2 (3 × 10 6 IU/vial) may used to manage feline leukemia virus, feline infectious peritonitis and feline immunodeficiency virus. 29

References Clinical Pharmacology, D.R. LAURENCE & P.N. BENNET Veterinary Applied Pharmacology and Therapeutics The Merck Veterinaty Manual DrugBank: 30